GlaxoSmithKline's total assets for Q3 2025 were £12.88B, a decrease of -78.27% from the previous quarter. GSK total liabilities were £3.00B for the fiscal quarter, a -93.33% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.